coronavirus
famili
positivesens
singlestrand
rna
virus
replic
cytoplasm
infect
cell
infecti
bronchiti
viru
ibv
highli
pathogen
respiratori
pathogen
chicken
also
affect
kidney
reproduct
system
raj
jone
cavanagh
therefor
result
bird
mortal
decreas
reproduct
ignjatov
sapat
coronavirus
ibv
input
genom
rna
translat
host
cell
ribosom
gener
rnadepend
rna
polymeras
lai
cavanagh
complex
respons
transcript
viral
subgenom
mrna
via
discontinu
mechan
pasternak
et
al
gener
new
genom
rna
genom
subgenom
mrna
cotermin
share
common
untransl
region
utr
wherea
end
genom
mrna
uniqu
utr
live
attenu
vaccin
use
prevent
infect
ibv
give
littl
crossstrain
immun
cavanagh
gelb
et
al
liu
et
al
problem
vaccin
effici
ibv
compound
due
extens
antigen
variat
differ
strain
jackwood
et
al
bochkov
et
al
caus
high
frequenc
mutat
due
errorpron
replic
also
recombin
wang
et
al
kottier
et
al
lee
jackwood
import
step
taken
control
ibv
infect
serolog
monitor
determin
viru
exposur
revers
transcriptasepolymeras
chain
reaction
rtpcr
detect
viral
rna
enzymelink
immunosorb
assay
haemagglutin
inhibit
detect
ibv
antibodi
adzhar
et
al
chen
et
al
due
high
probabl
new
emerg
strain
ibv
coronavirus
gener
sever
acut
respiratori
syndrom
coronaviru
peiri
et
al
need
develop
altern
strategi
vaccin
paramount
cavanagh
weiss
navasmartin
understand
action
lithium
chlorid
licl
replic
rang
dna
rna
virus
limit
licl
inhibit
replic
dna
viru
herp
simplex
skinner
et
al
wherea
rna
virus
encephalomyocard
viru
influenza
viru
appar
effect
viru
biolog
skinner
et
al
previou
studi
also
determin
inhibit
viru
specif
presenc
lithium
ion
reduct
viru
replic
seen
cell
treat
potassium
sodium
chlorid
skinner
et
al
follow
potenti
applic
licl
treat
dna
viru
infect
investig
antivir
effect
licl
ibv
two
cell
system
vero
cell
african
green
monkey
kidneyderiv
epitheli
cell
line
cell
immort
chicken
embryo
fibroblast
cell
line
although
vero
cell
use
extens
permiss
cell
line
studi
viru
replic
casai
et
al
britton
et
al
cell
biolog
dove
et
al
protein
target
dove
et
al
reed
et
al
recent
data
suggest
potenti
discrep
viru
biolog
term
protein
traffick
avian
mammalian
cell
line
pendleton
macham
therefor
vero
chicken
cell
use
studi
vero
cell
african
green
monkey
kidneyderiv
epitheli
cell
line
cell
doug
foster
chicken
embryo
fibroblastderiv
epitheli
cell
line
maintain
dulbecco
modifi
eagl
medium
supplement
foetal
bovin
serum
presenc
describ
previous
dove
et
al
ibv
beaudett
us
strain
adapt
growth
vero
cell
alonsocaplen
et
al
propag
vero
cell
viru
harvest
h
post
infect
pi
viru
titr
calcul
plaqu
assay
titrat
either
vero
cell
dove
et
al
cell
cultur
experi
conduct
absenc
antibiot
antifung
agent
vero
cell
seed
tissu
cultur
dish
grown
confluenc
prior
mock
infect
ibv
plaqueform
unitsml
h
pi
cell
treat
mm
licl
h
pi
mock
infect
cell
lyse
prepar
subsequ
plaqu
assay
mock
ibvinfect
vero
cell
harvest
h
pi
lyse
use
ripa
buffer
mm
tri
ph
mm
nacl
sodium
deoxychol
sodium
dodecyl
sulphat
complet
proteas
inhibitor
dilut
roch
total
protein
quantifi
bca
assay
promega
western
blot
analysi
perform
ten
microgram
total
protein
denatur
invitrogen
nupag
ld
sampl
reduc
buffer
contain
nupag
reduc
agent
separ
nupag
bistri
precast
gel
mop
run
buffer
protein
electrotransf
onto
polyvinyliden
fluorid
membran
transfer
buffer
contain
mm
bicin
mm
vv
methanol
western
blot
perform
use
luminol
sigma
ibv
protein
detect
use
chicken
antiibv
polyclon
antibodi
dilut
charl
river
mous
antigapdh
antibodi
dilut
abcam
use
detect
gapdh
horseradish
peroxidaseconjug
rabbit
antichicken
goat
antimous
secondari
antibodi
dilut
sigma
use
appropri
tissu
cultur
dish
seed
either
vero
cell
grown
confluent
serial
dilut
progeni
viru
perform
dulbecco
modifi
eagl
medium
foetal
bovin
serum
rang
ibv
grown
vero
cell
ibv
grown
cell
individu
well
infect
duplic
rang
viru
dilut
incub
presenc
h
overlaid
low
melt
point
agaros
dulbecco
modifi
eagl
medium
foetal
bovin
serum
cell
incub
h
stain
gentian
violet
crystal
violet
formaldehyd
etoh
phosphatebuff
salin
viru
titr
determin
count
number
plaqu
form
specif
dilut
dove
et
al
total
cellular
rna
extract
h
pi
rneasi
method
qiagen
accord
manufactur
instruct
ibv
genom
subgenom
rna
level
mock
virusinfect
vero
cell
treat
mm
licl
quantifi
taqman
realtim
rtpcr
exampl
see
kaiser
et
al
bicknel
et
al
primer
probe
ibv
utr
detect
genom
rna
cellular
rrna
design
use
primer
express
softwar
program
appli
biosystem
primer
probe
set
detect
ibv
utr
design
manual
softwar
detect
optimum
sequenc
primer
probe
set
use
studi
detail
tabl
base
upon
beaudett
us
strain
access
number
taqman
fast
univers
pcr
master
mix
multiscrib
rnase
inhibitor
mix
appli
biosystem
use
perform
realtim
quantit
rtpcr
detect
amplif
rna
level
use
utr
utr
probe
carri
use
taqman
machin
appli
biosystem
follow
cycl
profil
use
one
cycl
min
rt
step
sec
taq
activ
cycl
sec
melt
step
sec
anneal
extens
step
quantif
base
increas
fluoresc
detect
due
exonucleas
activ
taq
dna
polymeras
pcr
amplif
hydrolys
target
specif
probe
report
signal
normal
refer
dye
actual
involv
amplif
result
express
term
threshold
cycl
ct
valu
cycl
chang
report
dye
pass
signific
threshold
variat
sampl
rna
prepar
account
standard
ct
valu
ibv
utrspecif
utrspecif
product
sampl
ct
valu
rrna
product
sampl
rna
level
sampl
experi
normal
pool
valu
sampl
experi
calcul
mean
ct
valu
rrnaspecif
gene
product
variat
individu
rrna
sampl
compar
mean
calcul
differ
input
total
rna
calcul
determin
slope
rrna
dilut
seri
regress
line
use
slope
respect
ibv
utr
ibv
utr
rrna
dilut
seri
regress
line
differ
input
total
rna
repres
rrna
use
adjust
ibv
utrspecif
ibv
utrspecif
ct
valu
done
follow
ct
mean
sampl
ct
nt
experiment
mean
mean
sampl
ibv
utribv
utr
slope
slope
result
express
ct
valu
determin
whether
licl
inhibitori
effect
ibv
growth
vitro
vero
cell
infect
ibv
left
untreat
treat
increas
concentr
licl
rang
mm
viru
progeni
product
quantifi
plaqu
assay
h
pi
data
indic
lowest
concentr
licl
test
mm
approxim
reduct
viru
titr
compar
untreat
ibvinfect
cell
highest
concentr
mm
viru
progeni
product
abrog
determin
plaqu
assay
figur
although
data
indic
ibv
grew
better
cell
compar
vero
cell
evidenc
plaqu
format
dilut
progeni
viru
cell
compar
dilut
vero
cell
equival
reduct
viru
titr
licl
treatment
observ
vero
cell
appar
differ
plaqu
morpholog
ibv
vero
cell
likewis
concentr
treatment
licl
experi
licl
may
exert
inhibitori
effect
either
via
interf
viral
cellular
process
direct
virucid
effect
progeni
viru
present
supernat
would
result
drop
progeni
viru
product
therefor
distinguish
possibl
ie
determin
whether
licl
direct
virucid
effect
ibv
ml
prepar
ibv
plaqueform
unitsml
treat
mm
licl
control
concentr
viru
also
incub
h
h
either
assess
effect
temperatur
presenc
differ
concentr
licl
treatment
amount
viru
determin
plaqu
assay
data
indic
signific
variat
viru
titr
ibv
treat
rang
licl
concentr
therefor
licl
direct
virucid
effect
ibv
figur
howev
temperatur
shown
influenc
ibv
titr
viru
incub
h
titr
approxim
higher
viru
incub
h
viru
incub
h
viru
render
noninfecti
data
shown
determin
effect
licl
viru
protein
product
amount
ibv
nucleocapsid
n
protein
assay
western
blot
n
protein
bind
viral
rna
high
affin
chen
et
al
spencer
hiscox
one
abundantli
express
viral
protein
infect
cell
laud
master
thu
use
sensit
marker
viral
protein
product
potenti
effect
licl
cellular
protein
express
determin
examin
amount
gapdh
cellular
housekeep
protein
compar
total
protein
present
cell
lysat
prepar
either
mockinfect
ibvinfect
vero
cell
either
untreat
treat
mm
licl
yield
total
protein
determin
use
bca
assay
equival
amount
protein
extract
experiment
treatment
use
western
blot
analysi
data
indic
amount
n
protein
decreas
proport
amount
licl
treatment
appar
abrog
amount
n
protein
either
vero
cell
treat
mm
licl
western
blot
analysi
indic
amount
gapdh
vari
licltreat
untreat
vero
cell
thu
effect
licl
amount
protein
specif
ibv
figur
reduct
progeni
viru
product
could
therefor
due
decreas
amount
viru
protein
observ
infect
cell
treat
licl
may
result
either
reduct
translat
viral
subgenom
mrna
decreas
amount
subgenom
mrna
regard
former
possibl
translat
viral
cellular
mrna
cap
depend
licl
affect
would
predict
cellular
translat
would
also
decreas
howev
analysi
amount
gapdh
suggest
protein
unaffect
licl
therefor
licl
may
act
inhibitor
level
genom
rna
subgenom
mrna
synthesi
correspond
effect
translat
previou
studi
herp
simplex
viru
shown
licl
inhibit
dna
synthesi
skinner
et
al
therefor
possibl
tent
hypothes
licl
may
inhibit
rnadepend
rna
polymeras
characterist
posit
neg
strand
rna
virus
one
possibl
activ
compon
ibvencod
rnadepend
rna
polymeras
may
affect
licl
activ
sever
acut
respiratori
syndrom
coronaviru
helicas
magnesium
depend
tan
et
al
metal
ion
also
inhibit
activ
sever
acut
respiratori
syndrom
coronaviru
proteas
hsu
et
al
may
also
true
ibv
anoth
preced
inhibit
licl
activ
certain
cellular
protein
exampl
licl
inhibit
glycogen
synthas
kinas
beta
sever
differ
mechan
dobl
woodgett
jope
includ
competit
magnesium
ion
ryve
et
al
hypothes
test
compar
level
viral
rna
infect
cell
treat
untreat
licl
determin
effect
licl
viru
genom
subgenom
rna
level
taqman
rtpcr
analysi
perform
rna
extract
mock
infect
licltreat
cell
h
pi
use
primer
probe
set
design
ibv
utr
utr
respect
would
detect
genom
rna
utr
set
genom
rna
subgenom
mrna
utr
set
data
indic
vero
cell
treat
licl
overal
reduct
viral
rna
level
concentr
licl
increas
figur
b
respect
exampl
approxim
decreas
subgenom
mrna
level
untreat
cell
treat
mm
licl
vero
cell
ct
valu
repres
twofold
differ
rna
level
indic
amount
genom
rna
decreas
significantli
differ
mm
licl
treatment
howev
total
positivesens
rna
subgenom
genom
cell
gener
decreas
dosedepend
manner
except
mm
licl
concentr
licl
increas
may
account
gener
reduct
amount
n
protein
observ
infect
cell
treat
increas
concentr
licl
data
suggest
potenti
use
licl
antivir
agent
ibv
infer
term
common
genom
replic
strategi
coronavirus
whether
licl
could
use
field
ibv
remain
determin
certainli
would
applic
laboratori
studi
molecular
biolog
ibv
